Niacin is still beneficial. Implications from an updated meta-regression analysis
Niacin is still beneficial. Implications from an updated meta-regression analysis
Siniawski et al., 2016 | Acta Cardiol | Meta Analysis
Citation
Siniawski D, Santos-Gallego C G, ... Masson W M. Niacin is still beneficial. Implications from an updated meta-regression analysis. Acta Cardiol. 2016-Aug;71(4):463-72. doi:10.2143/AC.71.4.3159701
Abstract
No abstract available
Key Findings
Requires manual extraction from full text
Outcomes Measured
- Requires manual extraction
Population
| Field | Value |
|---|---|
| Population | See abstract |
| Sample Size | See abstract |
| Age Range | See abstract |
| Condition | See abstract |
MeSH Terms
- Cardiovascular Diseases
- Cholesterol, HDL
- Cholesterol, LDL
- Clinical Trials as Topic
- Humans
- Hypolipidemic Agents
- Niacin
- Risk Factors
- Treatment Outcome
- Triglycerides
Evidence Classification
- Level: Meta Analysis
- Publication Types: Journal Article, Meta-Analysis
- Vertical: niacin
Provenance
- PMID: 27594363
- DOI: 10.2143/AC.71.4.3159701
- PMCID: Not in PMC
- Verified: 2026-04-09 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-09